Aviceda

Aviceda Therapeutics

This biotechnology firm develops glycan-coated nanoparticle therapeutics to treat geographic atrophy and other inflammatory diseases for patients with vision loss.

ASHVATTHA THERAPEUTICS

This clinical-stage biopharmaceutical company develops targeted nanomedicine therapeutics for patients with inflammatory, neurological, and ophthalmic diseases including age-related macular degeneration.

Ikarovec

This company develops bicistronic gene therapies to treat chronic ophthalmic diseases, such as age-related macular degeneration, for patients suffering from vision loss.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Ollin Bio

This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.

PulseSight Therapeutics

This company develops non-viral gene therapies for patients with severe eye diseases including age-related macular degeneration.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.